You’re probably giving the author too much credit, IMO; I would say it’s more likely that he simply didn’t know about Botox for migraine. (By and large, I find articles by STAT to be wanting.)
Here’s another statement from the article that I find misleading, although it’s not an outright falsehood:
The above statement suggests that a migraine attack generates a simple CGRP-vs-time relationship that looks like an inverted “V”; however, the actual relationship is complex, due to positive feedback loops and factors that haven’t been fully elucidated.
The article also says:
Actually, you wouldn’t want to shut down CGRP completely (either by binding it directly or by blocking the receptor) because CGRP plays a role in the cardiovascular system. Thus, the anti-migraine drugs in development seek to reduce excess amounts of CGRP rather than to “stop CGRP in its tracks.”
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.